A5056167762- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- MRI in cancer diagnosis
- Prostate Cancer Diagnosis and Treatment
- Advanced X-ray and CT Imaging
- Advanced MRI Techniques and Applications
- Prostate Cancer Treatment and Research
- Radiation Dose and Imaging
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Diagnosis and Treatment
- Radiopharmaceutical Chemistry and Applications
- Rheumatoid Arthritis Research and Therapies
- Urologic and reproductive health conditions
- Cardiac Imaging and Diagnostics
- Bone and Joint Diseases
- Medical Imaging and Pathology Studies
- Advanced Neuroimaging Techniques and Applications
- Osteoarthritis Treatment and Mechanisms
- Lung Cancer Treatments and Mutations
- Spine and Intervertebral Disc Pathology
- Breast Cancer Treatment Studies
- Hip disorders and treatments
- Lanthanide and Transition Metal Complexes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastrointestinal Tumor Research and Treatment
Heinrich Heine University Düsseldorf
2016-2025
Düsseldorf University Hospital
2016-2025
Klinik und Poliklinik für Nuklearmedizin
2025
Dayton Interventional Radiology
2024
Integrated Oncology (United States)
2024
Essen University Hospital
2005-2022
German Cardiac Society
2021
Deutschen Konsortium für Translationale Krebsforschung
2020-2021
German Cancer Research Center
2015-2020
Deutsche Schmerzgesellschaft
2020
PURPOSE: To determine the accuracy of dual-modality positron emission tomographic (PET)–computed (CT) imaging, as compared with PET alone and CT alone, in staging non–small cell lung cancer (NSCLC). MATERIALS AND METHODS: Twenty-seven patients NSCLC underwent combined fluorine 18 fluorodeoxyglucose CT. CT, PET, coregistered PET/CT images were evaluated separately by two different physicians for each imaging modality, disease stage was determined using TNM American Joint Committee on Cancer...
ContextDeciding on the appropriate therapy for patients with malignant diseases mandates accurate tumor staging whole-body coverage. Magnetic resonance imaging (MRI) and a combined modality including positron emission tomography (PET) computed (CT) provide in single session.ObjectiveTo determine accuracies of both PET/CT MRI different diseases.Design, Setting, PatientsProspective, blinded, investigator-initiated study 98 (mean age, 58 years; range, 27-94 years) various oncological who...
Purpose To assess the accuracy of positron emission tomography/computed tomography (PET/CT) when staging different malignant diseases. Patients and Methods This was a retrospective, blinded, investigator-initiated study 260 patients with various oncological diseases who underwent fluorine-18–2-fluoro-2-deoxy-d-glucose PET/CT for tumor staging. CT images alone, PET + data viewed side by side, fused were evaluated separately according to tumor-node-metastasis system. One hundred forty tumors...
Radioembolization has been demonstrated to allow locoregional therapy of patients with hepatocellular carcinoma not eligible for transarterial chemoembolization or other local therapies. The aim this study was validate evidence the safety and efficacy treatment in a European sample advanced (HCC). Therefore, 108 consecutive HCC liver cirrhosis were included. Yttrium-90 (Y-90) microspheres administered lobar fashion over right left branch hepatic artery. response evaluated by computed...
Radiolabeled somatostatin analogs represent valuable tools for both in vivo diagnosis and therapy of neuroendocrine tumors (NETs) because the frequent tumoral overexpression receptors (sst). The 2 compounds most often used functional imaging with PET are <sup>68</sup>Ga-DOTATATE <sup>68</sup>Ga-DOTATOC. Both ligands share a quite similar sst binding profile. However, vitro affinity subtype (sst2) is approximately 10-fold higher than that This difference may affect their efficiency detection...
Abstract Purpose: To determine the value of combined positron emission tomography/computed tomography (PET/CT) during induction chemotherapy (CTx) followed by chemoradiotherapy (CTx/RTx) for non–small-cell lung cancer to predict histopathologic response in primary tumor and mediastinum prognosis patient. Experimental Design: Fifty consecutive patients with locally advanced received therapy and, if considered resectable, proceeded surgery (37 50 patients). Patients had at least two repeated...
PURPOSE: To retrospectively evaluate fused positron emission tomography (PET)/computed (CT) in depicting the primary lesion cancer of an unknown tumor, compared with PET, CT, and PET CT side-by-side evaluation. MATERIALS AND METHODS: Institutional review board approval informed consent were obtained. Forty-five patients (26 men 19 women) metastatic cervical adenopathy (n = 18) or extracervical metastases 27) tumor included. The mean age was 57 years (range, 29–95 years). PET/CT imaging...
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal of gastrointestinal tract. Long-term survival patients with metastatic disease has only been observed in completely resected disease. Recently, tyrosine kinase inhibitor imatinib found to yield responses majority GIST suggesting improved resectability responding patients. Combined treatment approaches including resective surgery after advanced have rarely explored. We report a series 90 whom enabled 12 mostly recurrent...